Search - tctmd.com

Displaying 561 - 580 of 1860

Sort: Relevancy | Date

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

February 28, 2020

BBC Makes New EXCEL Allegations, Says Investigators Ignored Safety Concerns

News Daily News

BBC Makes New EXCEL Allegations, Says Investigators Ignored Safety Concerns

Michael O'Riordan

February 21, 2020

Another Neuroprotective Agent Fails in Acute Stroke . . . Or Does It?

News Conference News ISC 2020

Another Neuroprotective Agent Fails in Acute Stroke . . . Or Does It?

February 21, 2020

Coronavirus: CV Meeting Planners Keeping an Eye on Evolving Situation

News Daily News

Coronavirus: CV Meeting Planners Keeping an Eye on Evolving Situation

February 04, 2020

News Daily News

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

January 15, 2020

Conversations in Cardiology: In the ISCHEMIA Era, What Role for FFR?

News Opinion Conversations in Cardiology

Conversations in Cardiology: In the ISCHEMIA Era, What Role for FFR?

January 02, 2020

News Daily News

NOBLE at 5 Years: New Data Favor CABG for Left Main Disease

December 23, 2019

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

News Features

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

December 23, 2019

EACTS Calls for Independent Left Main CAD Evidence Review, Urges ESC Input

News Daily News

EACTS Calls for Independent Left Main CAD Evidence Review, Urges ESC Input

December 20, 2019

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

News Daily News

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Michael O'Riordan

December 20, 2019

Oxygen of No Benefit, Even in MI Patients With Low-Normal Saturation

News Daily News

Oxygen of No Benefit, Even in MI Patients With Low-Normal Saturation

Michael O'Riordan

December 16, 2019

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

News Daily News

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Michael O'Riordan

December 10, 2019

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

December 10, 2019

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

News Conference News PCR London Valves 2019

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Michael O'Riordan

November 25, 2019

Sex Differences, EF Thresholds Probed for Sacubitril/Valsartan in Heart Failure

News Conference News AHA 2019

Sex Differences, EF Thresholds Probed for Sacubitril/Valsartan in Heart Failure

November 22, 2019

More Adverse Events, Higher Costs With Impella: New Observational Studies

News Conference News AHA 2019

More Adverse Events, Higher Costs With Impella: New Observational Studies

November 17, 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

November 17, 2019

COLCOT Renews Hope for Anti-inflammatory Secondary Prevention

News Conference News AHA 2019

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

November 16, 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

November 11, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.